SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-024987
Filing Date
2022-11-14
Accepted
2022-11-14 16:10:34
Documents
84
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cmra-20220930.htm   iXBRL 10-Q 3642273
2 EX-31.1 cmra-ex31_1.htm EX-31.1 26852
3 EX-31.2 cmra-ex31_2.htm EX-31.2 26887
4 EX-32.1 cmra-ex32_1.htm EX-32.1 16873
5 EX-32.2 cmra-ex32_2.htm EX-32.2 17128
  Complete submission text file 0000950170-22-024987.txt   10881213

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cmra-20220930_cal.xml EX-101.CAL 53765
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cmra-20220930_lab.xml EX-101.LAB 543237
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cmra-20220930.xsd EX-101.SCH 84610
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cmra-20220930_pre.xml EX-101.PRE 433119
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cmra-20220930_def.xml EX-101.DEF 294214
78 EXTRACTED XBRL INSTANCE DOCUMENT cmra-20220930_htm.xml XML 1625971
Mailing Address 12 GILL STREET SUITE 4650 WOBURN MA 01801
Business Address 12 GILL STREET SUITE 4650 WOBURN MA 01801 617.871.2101 EXT 313
Comera Life Sciences Holdings, Inc. (Filer) CIK: 0001907685 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41403 | Film No.: 221385295
SIC: 2834 Pharmaceutical Preparations